GlassScriptPhysician profile
Forum Patel
NPI 1922538354
$4,053.12
in general payments reported to CMS, 2019-2025
22 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $191 · 2021: $1,268 · 2022: $830 · 2023: $323 · 2024: $246 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $554.41 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $395.51 | 2021 | |
| Glaukos Corporation | $363.65 | 2021 | |
| Oyster Point Pharma, INC. | $334.23 | 2022-2024 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $315.46 | 2022 | |
| Bausch & Lomb Americas INC. | $281.01 | 2023-2024 | Envista Mx60 Iol, Toric, Xiidra |
| Aerie Pharmaceuticals, INC. | $247.21 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $242.35 | 2019 | |
| Sight Sciences, INC. | $214.88 | 2020-2022 | |
| Alcon Vision LLC | $140.26 | 2021-2024 | Rocklatan |
| Horizon Therapeutics Plc | $138.61 | 2021-2022 | |
| Pfizer INC. | $125.00 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $125.00 | 2019 | |
| Shire North American Group INC | $125.00 | 2019 | |
| Harrow Eye, LLC | $121.11 | 2025 | Vevye |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $91.35 | 2021 | |
| Sun Pharmaceutical Industries INC. | $73.10 | 2023 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $52.30 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $36.93 | 2021-2022 | |
| Abbvie INC. | $33.30 | 2023 | |
| Dermira, INC. | $22.50 | 2019 | |
| Thea Pharma INC. | $19.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Forum Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.